NL191432B - Pharmaceutical composition comprising naproxen and another active compound. - Google Patents

Pharmaceutical composition comprising naproxen and another active compound.

Info

Publication number
NL191432B
NL191432B NL8320240A NL8320240A NL191432B NL 191432 B NL191432 B NL 191432B NL 8320240 A NL8320240 A NL 8320240A NL 8320240 A NL8320240 A NL 8320240A NL 191432 B NL191432 B NL 191432B
Authority
NL
Netherlands
Prior art keywords
naproxen
pharmaceutical composition
active compound
another active
another
Prior art date
Application number
NL8320240A
Other languages
Dutch (nl)
Other versions
NL8320240A (en
NL191432C (en
Original Assignee
Richardson Vicks
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Vicks filed Critical Richardson Vicks
Publication of NL8320240A publication Critical patent/NL8320240A/en
Publication of NL191432B publication Critical patent/NL191432B/en
Priority to NL9500644A priority Critical patent/NL9500644A/en
Priority to NL9500645A priority patent/NL9500645A/en
Application granted granted Critical
Publication of NL191432C publication Critical patent/NL191432C/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
NL8320240A 1982-07-22 1983-07-21 Pharmaceutical composition comprising naproxen and another active compound. NL191432C (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NL9500644A NL9500644A (en) 1982-07-22 1995-06-27 Pharmaceutical preparation comprising fenoprofen
NL9500645A NL9500645A (en) 1982-07-22 1995-06-27 Pharmaceutical preparation comprising diflunisal

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US40059782A 1982-07-22 1982-07-22
US40059782 1982-07-22
PCT/US1983/001121 WO1984000488A1 (en) 1982-07-22 1983-07-21 Improved analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US8301121 1983-07-21

Publications (3)

Publication Number Publication Date
NL8320240A NL8320240A (en) 1984-06-01
NL191432B true NL191432B (en) 1995-03-01
NL191432C NL191432C (en) 1995-07-04

Family

ID=23584242

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8320240A NL191432C (en) 1982-07-22 1983-07-21 Pharmaceutical composition comprising naproxen and another active compound.

Country Status (15)

Country Link
JP (3) JPS59501460A (en)
AT (2) AT389226B (en)
AU (1) AU558485B2 (en)
BE (1) BE897356A (en)
CA (1) CA1217429A (en)
CH (1) CH659391A5 (en)
DE (1) DE3390116C2 (en)
FR (1) FR2530469A1 (en)
GB (1) GB2134786B (en)
IE (1) IE55367B1 (en)
IT (1) IT1206502B (en)
NL (1) NL191432C (en)
SE (1) SE466481B (en)
WO (1) WO1984000488A1 (en)
ZA (2) ZA835324B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559343A (en) * 1982-09-07 1985-12-17 Alcon Laboratories, Inc. Nonirritating aqueous ophthalmic compositions comfort formulation for ocular therapeutic agents
US4567183A (en) * 1983-03-11 1986-01-28 Analgesic Associates Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4558051A (en) * 1983-10-11 1985-12-10 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
CH664085A5 (en) * 1985-02-08 1988-02-15 Ciba Geigy Ag PHARMACEUTICAL PREPARATIONS WITH ANALGETIC EFFECTIVENESS AND THEIR PRODUCTION.
CH669523A5 (en) * 1986-06-25 1989-03-31 Mepha Ag
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
US20040115290A1 (en) 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
EP1414458B1 (en) 2001-07-06 2007-04-11 Endo Pharmaceuticals Inc. Oral administration of 6-hydroxy-oxymorphone for use as an analgesic
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
US7914831B2 (en) * 2004-02-27 2011-03-29 Metaproteomics, Llc Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
JP2006282644A (en) * 2005-04-05 2006-10-19 Idemitsu Kosan Co Ltd Fatigue recovery agent
TW201247195A (en) * 2011-04-28 2012-12-01 Kowa Co Stable pharmaceutical composition
JP2018076305A (en) * 2016-10-31 2018-05-17 エスエス製薬株式会社 Pharmaceutical composition
JP2021054728A (en) * 2019-09-27 2021-04-08 興和株式会社 Pharmaceutical
JP6811453B1 (en) * 2020-06-24 2021-01-13 医療法人すぎやま内科 Composition for transdermal absorption

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3439094A (en) * 1967-07-20 1969-04-15 Warner Lambert Pharmaceutical Analgesic compositions containing namol xenyrate,caffeine and acetyl-rho-aminophenol
US4049803A (en) * 1976-04-26 1977-09-20 Bristol-Myers Company Augmentation of blood levels of aspirin
JPS5423132A (en) * 1977-07-19 1979-02-21 Dai Ichi Seiyaku Co Ltd Analgesic composition
JPS54154416A (en) * 1978-05-26 1979-12-05 Tdk Electronics Co Ltd High dielectric constant porcelain composition
US4233314A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4233316A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4233315A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4234601A (en) * 1978-12-18 1980-11-18 Mcneilab, Inc. Analgesic potentiation
US4233317A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4237140A (en) * 1979-05-18 1980-12-02 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and acetaminophen
US4315936A (en) * 1979-12-17 1982-02-16 Ortho Pharmaceutical Corporation Analgesic composition
JPS56154416A (en) * 1980-04-30 1981-11-30 Kaken Pharmaceut Co Ltd Antipyretic analgesic composition
US4322427A (en) * 1981-04-16 1982-03-30 Bristol-Myers Company Analgetic compositions and methods of use
US4420483A (en) * 1982-07-22 1983-12-13 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same

Also Published As

Publication number Publication date
AT389998B (en) 1990-02-26
AU1881683A (en) 1984-02-23
IE831715L (en) 1984-01-22
IT1206502B (en) 1989-04-27
IE55367B1 (en) 1990-08-29
SE8401538D0 (en) 1984-03-20
AU558485B2 (en) 1987-01-29
IT8322173A0 (en) 1983-07-21
FR2530469A1 (en) 1984-01-27
AT389226B (en) 1989-11-10
SE466481B (en) 1992-02-24
DE3390116C2 (en) 1994-06-16
GB2134786B (en) 1986-05-08
BE897356A (en) 1983-11-14
SE8401538L (en) 1984-03-20
WO1984000488A1 (en) 1984-02-16
ATA245988A (en) 1989-08-15
JPH07165583A (en) 1995-06-27
GB2134786A (en) 1984-08-22
GB8406704D0 (en) 1984-04-18
NL8320240A (en) 1984-06-01
ZA835326B (en) 1984-09-26
DE3390116T1 (en) 1985-01-10
JPS59501459A (en) 1984-08-16
ATA903983A (en) 1989-04-15
NL191432C (en) 1995-07-04
CA1217429A (en) 1987-02-03
JPS59501460A (en) 1984-08-16
CH659391A5 (en) 1987-01-30
ZA835324B (en) 1984-09-26

Similar Documents

Publication Publication Date Title
NL193419B (en) Topically applicable pharmaceutical compositions.
IT8322171A0 (en) IMPROVED ANALGESIC AND ANTI-INFLAMMATORY COMPOSITIONS, CONTAINING CAFFEINE.
BR1100036A (en) Pharmaceutical composition and composition
DE3486255D1 (en) Pharmaceutical compositions.
DE3483133D1 (en) PHARMACEUTICAL COMPOSITIONS.
ES520749A0 (en) PERFECTED COMBINE.
NL192201B (en) Pharmacologically active phenylaminoalkylcyclobutane compounds and compositions containing these compounds.
FR2547727B1 (en) PHARMACEUTICAL COMPOSITIONS
DE3485408D1 (en) PHARMACEUTICAL COMPOSITION.
NL188905C (en) ANTHRACYCLINE COMPOUND AND PHARMACEUTICAL PREPARATION.
NL191432C (en) Pharmaceutical composition comprising naproxen and another active compound.
IT1206693B (en) IMPROVED ANALGESIC AND ANTI-INFLAMMATORY COMPOSITIONS CONTAINING IBUPROFEN.
DE3382112D1 (en) PHARMACEUTICAL COMPOSITION.
IT8621192A0 (en) PHARMACEUTICAL COMPOSITION.
MX9203639A (en) 3-PHENOXI-1-AZETIDINCARBOXAMIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
ES519865A0 (en) AN EXTRUIBLE AND RETICULABLE COMPOSITION.
BE896711A (en) ANTI-ULCER PHARMACEUTICAL COMPOSITIONS.
ATE36455T1 (en) PHARMACEUTICAL COMPOSITIONS.
DE3483900D1 (en) PHARMACEUTICAL COMPOSITIONS.
IT8548964A0 (en) 8ALFA-ACYLAMINOERGOLINES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
IT1206323B (en) PHARMACEUTICAL PREPARATIONS WITH CYTOSTATIC ACTION.
DE3381646D1 (en) THERMOCHROME COMPOSITION.
OA07489A (en) Synergistic antihypertensive pharmaceutical composition.
IT1197578B (en) ERGOPEPTIDAL ALCALOIDS, THEIR PREPARATION AND MEDICATIONS CONTAINING THESE COMPOUNDS
IT8222757A0 (en) ANTIATEROMASIC PHARMACEUTICAL COMPOSITION.

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20030721